Filing Manager
CITADEL ADVISORS LLC
Reporting Manager
Kenneth Griffin
Symbol
CGEM
Shares outstanding
59,002,471 shares
Disclosed Ownership
3,009,126 shares
Ownership
5.1%
Form type
SCHEDULE 13G
Filing time
06 Aug 2025, 18:55:46 UTC
Date of event
30 Jul 2025
Next filing
14 Nov 2025

Quoteable Key Fact

"CITADEL ADVISORS LLC disclosed 5.1% ownership in Cullinan Therapeutics, Inc. Common Stock, par value $0.0001 per share (the "Shares") (CGEM) on 30 Jul 2025."

Quick Takeaways

  • CITADEL ADVISORS LLC filed SCHEDULE 13G for Cullinan Therapeutics, Inc. Common Stock, par value $0.0001 per share (the "Shares") (CGEM).
  • Disclosed ownership: 5.1%.
  • Date of event: 30 Jul 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 06 Aug 2025, 18:55.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Citadel Advisors LLC 4.3% 2,511,191 0 2,511,191 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Advisors Holdings LP 4.3% 2,511,191 0 2,511,191 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel GP LLC 4.3% 2,511,191 0 2,511,191 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities LLC 0.8% 497,935 0 497,935 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities Group LP 0.8% 497,935 0 497,935 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities GP LLC 0.8% 497,935 0 497,935 /s/ Seth Levy Seth Levy, Authorized Signatory
Kenneth Griffin 5.1% 3,009,126 0 3,009,126 /s/ Seth Levy Seth Levy, attorney-in-fact*